[go: up one dir, main page]

ZA200903442B - Renin inhibitors for the prevention and treatment of hypertension in obese patients - Google Patents

Renin inhibitors for the prevention and treatment of hypertension in obese patients

Info

Publication number
ZA200903442B
ZA200903442B ZA200903442A ZA200903442A ZA200903442B ZA 200903442 B ZA200903442 B ZA 200903442B ZA 200903442 A ZA200903442 A ZA 200903442A ZA 200903442 A ZA200903442 A ZA 200903442A ZA 200903442 B ZA200903442 B ZA 200903442B
Authority
ZA
South Africa
Prior art keywords
hypertension
prevention
treatment
renin inhibitors
obese patients
Prior art date
Application number
ZA200903442A
Other languages
English (en)
Inventor
Margaret Forney Prescott
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39186152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200903442(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200903442B publication Critical patent/ZA200903442B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200903442A 2006-12-15 2009-05-19 Renin inhibitors for the prevention and treatment of hypertension in obese patients ZA200903442B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87018006P 2006-12-15 2006-12-15

Publications (1)

Publication Number Publication Date
ZA200903442B true ZA200903442B (en) 2010-05-26

Family

ID=39186152

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200903442A ZA200903442B (en) 2006-12-15 2009-05-19 Renin inhibitors for the prevention and treatment of hypertension in obese patients

Country Status (18)

Country Link
US (1) US20100029775A1 (fr)
EP (1) EP2094259A1 (fr)
JP (1) JP2010513300A (fr)
KR (1) KR20090090384A (fr)
CN (1) CN101583355A (fr)
AU (1) AU2007333095B2 (fr)
BR (1) BRPI0721167A2 (fr)
CA (1) CA2672579A1 (fr)
CL (1) CL2007003628A1 (fr)
IL (1) IL198876A0 (fr)
MA (1) MA31003B1 (fr)
MX (1) MX2009006340A (fr)
NO (1) NO20092597L (fr)
RU (1) RU2009126741A (fr)
TN (1) TN2009000240A1 (fr)
TW (1) TW200831071A (fr)
WO (1) WO2008074001A1 (fr)
ZA (1) ZA200903442B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2143425A1 (fr) * 2008-07-11 2010-01-13 Ratiopharm GmbH Tablettes d'aliskiren comprimées directement

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168616B1 (en) * 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
TW200538154A (en) * 2004-02-17 2005-12-01 Novartis Ag Combination of organic compounds
WO2005089731A2 (fr) * 2004-03-17 2005-09-29 Novartis Ag Utilisation de composes organiques
WO2007047351A2 (fr) * 2005-10-13 2007-04-26 Orexigen Therapeutics, Inc. Méthodes pour traiter l'hypertension chez des individus en surpoids et obèses
WO2007146900A2 (fr) * 2006-06-15 2007-12-21 Gilead Colorado, Inc. Procédé de traitement antihypertenseur

Also Published As

Publication number Publication date
CA2672579A1 (fr) 2008-06-19
NO20092597L (no) 2009-07-13
JP2010513300A (ja) 2010-04-30
WO2008074001A8 (fr) 2009-07-02
TN2009000240A1 (en) 2010-10-18
IL198876A0 (en) 2010-02-17
KR20090090384A (ko) 2009-08-25
CN101583355A (zh) 2009-11-18
MX2009006340A (es) 2009-06-23
AU2007333095B2 (en) 2011-03-24
BRPI0721167A2 (pt) 2014-03-18
RU2009126741A (ru) 2011-01-20
MA31003B1 (fr) 2009-12-01
TW200831071A (en) 2008-08-01
AU2007333095A1 (en) 2008-06-19
US20100029775A1 (en) 2010-02-04
CL2007003628A1 (es) 2008-07-18
EP2094259A1 (fr) 2009-09-02
WO2008074001A1 (fr) 2008-06-19

Similar Documents

Publication Publication Date Title
EP2043727A4 (fr) Dispositifs et procédés destinés au traitement de l'obésité
PL1981516T3 (pl) Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom
IL194820A0 (en) Devices and methods for treatment of tissue
EP2026843A4 (fr) Utilisations thérapeutiques d'inhibiteurs de rtp801l
EP2081638A4 (fr) Appareil et procédés pour le traitement à peine invasif de l'obésité
IL195400A0 (en) Aldh-2 inhibitors in the treatment of addiction
IL201114A0 (en) Combination of blys inhibition and/or april inhibition and immunosuppressants for treatment of autoimmune disease
EP2007385A4 (fr) Composition cardiovasculaire et utilisation de ladite composition pour le traitement de la maladie d'alzheimer
EP2148677A4 (fr) Inhibiteurs de kinase utiles pour le traitement de maladies myéloprolifératives et autres maladies prolifératives
EP1803460A4 (fr) Préparation et méthode prophylactiques ou thérapeutiques contre un symptome mental
IL190201A0 (en) Pde inhibitors and combinations thereof for the treatment of urological disorders
IL195615A0 (en) Methods and devices for treatment of cardiac valves
IL192694A0 (en) Combination of ache inhibitor and 5-ht6 antagonist for the treatment of cognitive dysfunction
EP1991270A4 (fr) Compositions et procédés pour la prévention et le traitement de la cachexie
IL198723A0 (en) Methods and compositions for therapeutic treatment
IL198461A (en) 3 alpha androstandiol and type 5 phosphodiesterase inhibitor (pde5 for on-demand use in the treatment of sexual dysfunction
GB0610350D0 (en) prevention and/or treatment of neuodegenerative disorders
IL202307A0 (en) Multikinase inhibitors for use in the treatment of cancer
IL192031A0 (en) Use of cicletanine and other furopyridines for treatment of hypertension
IL178100A0 (en) 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
ZA200807357B (en) Inhibitors of PAI-1 for treatment of muscular conditions
IL193905A0 (en) Renin inhibitors for the treatment of hypertension
IL198876A0 (en) Renin inhibitors for the prevention and treatment of hypertension in obese patients
HK1132674A (en) Renin inhibitors for the prevention and treatment of hypertension in obese patients
GB2441094B (en) Methods for treatment and prevention of infection